Eisai is a company deeply committed to the development of innovative solutions in the treatment of neurological diseases, and to addressing the unmet medical needs in this therapeutic area
Eisai, at global level, has identified a number of therapeutical areas which include neuroscience, oncology, vascular and immunology, where several unmet medical needs exist and where we have compounds on different phases of development and research.
Being that way, Eisai positions Neurology and Oncology as two strategically important therapeutic areas where we can discover “Ricchi”, areas where patients true needs remain unmet and we can become a front-runner. Accordingly, we are promoting drug discovery activities in these two areas. By targeting treatments for specific indication in selected therapeutic areas it is how we believe we can become really productive and efficient; and working at this level of expertise we can then create new formulations, ensure new quality products and that further indications get approval in these therapeutic areas.